These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the García-López M; Jiménez-Vicente L; González-Jabardo R; Dorado H; Gómez-Manjón I; Martín MÁ; Ayuso C; Arenas J; Gallardo ME Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000346 [TBL] [Abstract][Full Text] [Related]
5. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy. Yu-Wai-Man P; Davies VJ; Piechota MJ; Cree LM; Votruba M; Chinnery PF Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4561-6. PubMed ID: 19443720 [TBL] [Abstract][Full Text] [Related]
10. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. Lei Q; Xiang K; Cheng L; Xiang M Stem Cell Reports; 2024 Jan; 19(1):68-83. PubMed ID: 38101398 [TBL] [Abstract][Full Text] [Related]
11. Characterisation of a novel OPA1 splice variant resulting in cryptic splice site activation and mitochondrial dysfunction. Harvey JP; Yu-Wai-Man P; Cheetham ME Eur J Hum Genet; 2022 Jul; 30(7):848-855. PubMed ID: 35534703 [TBL] [Abstract][Full Text] [Related]
12. The human OPA1 Affortit C; Coyat C; Saidia AR; Ceccato JC; Charif M; Sarzi E; Flamant F; Guyot R; Cazevieille C; Puel JL; Lenaers G; Wang J Cell Mol Life Sci; 2024 Feb; 81(1):80. PubMed ID: 38334784 [TBL] [Abstract][Full Text] [Related]
13. OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts. Zanfardino P; Amati A; Doccini S; Cox SN; Tullo A; Longo G; D'Erchia A; Picardi E; Nesti C; Santorelli FM; Petruzzella V Hum Mol Genet; 2024 Apr; 33(9):768-786. PubMed ID: 38280232 [TBL] [Abstract][Full Text] [Related]
14. Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct Pohl KA; Zhang X; Pham AH; Chan JW; Sadun AA; Yang XJ Front Genet; 2023; 14():1251216. PubMed ID: 37745862 [TBL] [Abstract][Full Text] [Related]
15. OPA1 deficiency impairs oxidative metabolism in cycling cells, underlining a translational approach for degenerative diseases. Millet AMC; Coustham C; Champigny C; Botella M; Demeilliers C; Devin A; Galinier A; Belenguer P; Bordeneuve-Guibé J; Davezac N; Merabet N Dis Model Mech; 2023 Sep; 16(9):. PubMed ID: 37497665 [TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 correction of Sladen PE; Perdigão PRL; Salsbury G; Novoselova T; van der Spuy J; Chapple JP; Yu-Wai-Man P; Cheetham ME Mol Ther Nucleic Acids; 2021 Dec; 26():432-443. PubMed ID: 34589289 [TBL] [Abstract][Full Text] [Related]
19. High-throughput screening identifies suppressors of mitochondrial fragmentation in OPA1 fibroblasts. Cretin E; Lopes P; Vimont E; Tatsuta T; Langer T; Gazi A; Sachse M; Yu-Wai-Man P; Reynier P; Wai T EMBO Mol Med; 2021 Jun; 13(6):e13579. PubMed ID: 34014035 [TBL] [Abstract][Full Text] [Related]
20. [Chinese expert consensus on the clinical diagnosis and treatment of autosomal dominant optic atrophy (2024)]. ; Zhonghua Yan Ke Za Zhi; 2024 Mar; 60(3):226-233. PubMed ID: 38462370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]